Literature DB >> 22968358

Cytostatic and cytotoxic effects of 5-fluorouracil on human corneal epithelial cells and keratocytes.

Edoardo Midena1, Daniela Lazzarini, Anton Giulio Catania, Erika Moretto, Iva Fregona, Raffaele Parrozzani.   

Abstract

PURPOSE: To investigate the effects of various 5-fluorouracil (5-FU) concentrations, exposure times, and application techniques on in vitro-cultured human corneal cells.
METHODS: Human corneal epithelial cell (HCEC) and human corneal keratocyte (HCK) cultures were exposed to different 5-FU concentrations (0.025%-1%) and incubation durations (5 minutes to 2 hours). The cytostatic effect was evaluated as the percentage of inhibition of migration relative to the control. The evaluation of cytotoxic effect included both phase contrast microscopic observations and viability measures performed using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] colorimetric assay. The results are expressed as ratio of optical density (OD) reduction 24 hours after exposure.
RESULTS: The cytostatic effect was time and dose dependent. The 50% inhibiting dose was 0.55% after 1 hour of incubation for HCECs and was 0.5% after 2 hours of incubation for HCKs. A 100% inhibitory effect was never observed at any concentration or incubation duration. No cytotoxic changes were observed using an 5-FU concentration of <1%; 1% 5-FU showed time-dependent cytotoxic changes in HCEC cultures only. MTT analysis showed no OD reduction at 5-FU concentrations of <1%, whereas 1% 5-FU showed OD reduction <50% at any tested exposure time. HCECs showed higher reduction in OD than HCKs.
CONCLUSIONS: 5-FU formulations topically used in clinical practice showed limited toxicity in normal cultured corneal epithelial cells and keratocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22968358     DOI: 10.1097/ICO.0b013e31825d56c1

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

Review 1.  Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.

Authors:  Nattawut Leelakanok; Sean Geary; Aliasger Salem
Journal:  J Pharm Sci       Date:  2017-10-16       Impact factor: 3.784

2.  Corneal limbal stem cell deficiency associated with the anticancer drug S-1.

Authors:  Kyeong Hwan Kim; Wan Soo Kim
Journal:  Optom Vis Sci       Date:  2015-04       Impact factor: 1.973

3.  Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.

Authors:  Raffaele Parrozzani; Luisa Frizziero; Sara Trainiti; Ilaria Testi; Giacomo Miglionico; Elisabetta Pilotto; Stella Blandamura; Ambrogio Fassina; Edoardo Midena
Journal:  Br J Ophthalmol       Date:  2016-12-09       Impact factor: 4.638

4.  Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.

Authors:  Seungil Kim; Sarah Choung; Ren X Sun; Nolan Ung; Natasha Hashemi; Emma J Fong; Roy Lau; Erin Spiller; Jordan Gasho; Jasmine Foo; Shannon M Mumenthaler
Journal:  SLAS Discov       Date:  2020-04-30       Impact factor: 3.341

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.